Küpper J H, Müller M, Jacobson M K, Tatsumi-Miyajima J, Coyle D L, Jacobson E L, Bürkle A
Abteilung 0610, Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Mol Cell Biol. 1995 Jun;15(6):3154-63. doi: 10.1128/MCB.15.6.3154.
Poly(ADP-ribosyl)ation is a posttranslational modification of nuclear proteins catalyzed by poly(ADP-ribose) polymerase (PARP; EC 2.4.2.30), with NAD+ serving as the substrate. PARP is strongly activated upon recognition of DNA strand breaks by its DNA-binding domain. Experiments with low-molecular-weight inhibitors of PARP have led to the view that PARP activity plays a role in DNA repair and possibly also in DNA replication, cell proliferation, and differentiation. Accumulating evidence for nonspecific inhibitor effects prompted us to develop a molecular genetic system to inhibit PARP in living cells, i.e., to overexpress selectively the DNA-binding domain of PARP as a dominant negative mutant. Here we report on a cell culture system which allows inducible, high-level expression of the DNA-binding domain. Induction of this domain leads to about 90% reduction of poly(ADP-ribose) accumulation after gamma-irradiation and sensitizes cells to the cytotoxic effect of gamma-irradiation and of N-methyl-N'-nitro-N-nitrosoguanidine. In contrast, induction does not affect normal cellular proliferation or the replication of a transfected polyomavirus replicon. Thus, trans-dominant inhibition of the poly(ADP-ribose) accumulation occurring after gamma-irradiation or N-methyl-N'-nitro-N-nitrosoguanidine is specifically associated with a disturbance of the cellular recovery from the inflicted damage.
聚(ADP-核糖)化是一种由聚(ADP-核糖)聚合酶(PARP;EC 2.4.2.30)催化的核蛋白翻译后修饰,以NAD⁺作为底物。PARP的DNA结合结构域识别DNA链断裂后会被强烈激活。使用PARP的低分子量抑制剂进行的实验使人们认为PARP活性在DNA修复中起作用,也可能在DNA复制、细胞增殖和分化中起作用。越来越多关于非特异性抑制剂作用的证据促使我们开发一种分子遗传系统来在活细胞中抑制PARP,即选择性地过表达PARP的DNA结合结构域作为显性负突变体。在此我们报道一种细胞培养系统,该系统允许诱导性、高水平表达DNA结合结构域。诱导该结构域会导致γ射线照射后聚(ADP-核糖)积累减少约90%,并使细胞对γ射线照射和N-甲基-N'-硝基-N-亚硝基胍的细胞毒性作用敏感。相比之下,诱导并不影响正常细胞增殖或转染的多瘤病毒复制子的复制。因此,γ射线照射或N-甲基-N'-硝基-N-亚硝基胍后发生的聚(ADP-核糖)积累的反式显性抑制与细胞从所受损伤中恢复的干扰特异性相关。